KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iqvia Holdings (IQV) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Iqvia Holdings (IQV) over the last 15 years, with Q4 2025 value amounting to $2.0 billion.

  • Iqvia Holdings' Cash & Equivalents rose 1633.37% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 1633.37%. This contributed to the annual value of $2.0 billion for FY2025, which is 1633.37% up from last year.
  • Per Iqvia Holdings' latest filing, its Cash & Equivalents stood at $2.0 billion for Q4 2025, which was up 1633.37% from $1.8 billion recorded in Q3 2025.
  • Iqvia Holdings' 5-year Cash & Equivalents high stood at $2.3 billion for Q1 2021, and its period low was $1.2 billion during Q4 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $1.5 billion (2021), whereas its average is $1.6 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first skyrocketed by 14865.16% in 2021, then crashed by 3982.65% in 2022.
  • Over the past 5 years, Iqvia Holdings' Cash & Equivalents (Quarter) stood at $1.4 billion in 2021, then decreased by 10.98% to $1.2 billion in 2022, then increased by 13.16% to $1.4 billion in 2023, then increased by 23.69% to $1.7 billion in 2024, then increased by 16.33% to $2.0 billion in 2025.
  • Its Cash & Equivalents was $2.0 billion in Q4 2025, compared to $1.8 billion in Q3 2025 and $2.0 billion in Q2 2025.